Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.
Ping-I HsuFeng-Woei TsayJohn Y KaoNan-Jing PengYan-Hua ChenSheng-Yeh TangChao-Hung KuoSung-Shuo KaoHuay-Min WangI-Ting WuChang-Bih ShieSeng-Kee ChuahDeng-Chyang Wunull nullPublished in: Helicobacter (2021)
Ten-day TL quadruple therapy is more effective than AL quadruple therapy in the second-line treatment of H. pylori infection in a population with high levofloxacin resistance.